These dosages are typically given to treat deficiency resulting from pernicious anemia, gastrointestinal disorders (such as Crohns disease), malabsorption syndromes, gastric surgeries and long-term use of medications (such as proton pump inhibitors)
The compound lacks the androgenic properties necessary for significant protein synthesis and cellular hypertrophy
Those suffering from anaemia caused by B12 deficiency are likely to experience fewer symptoms, such as breathlessness and weakness, during this period
But anyone with cancer history should avoid both
Most of the excitement around BPC-157 peptide therapy comes from preclinical research and mechanistic studies
Results vary based on what you are treating, your overall health, and how long the issue has been present